SCHEMBL12508142

SCHEMBL12508142

Cc1ccc(-c2ncc(Cl)cc2Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.49
DHODH Q02127 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PTGS2 P35354 7/20 0.40
PTGS1 P23219 3/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ABCC4 O15439 1/20 0.39
ABCB11 O95342 1/20 0.39
PDE4D Q08499 1/20 0.39
MAPK14 Q16539 1/20 0.39
PIK3CG P48736 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17720584 0.86 ALDH1A1 (0.44) CNR2SMN1; SMN2L3MBTL1HSP90AB1MAPT
SCHEMBL4181890 0.81 PTGS2 (0.57) CNR2SMN1; SMN2LMNAPTGS2PTGS1
SCHEMBL12418428 0.81 CNR2 (0.47) CNR2SMN1; SMN2LMNAPTGS2PTGS1
SCHEMBL18356746 0.81 MAPK1 (0.53) CNR2SMN1; SMN2LMNAL3MBTL1HSP90AB1
SCHEMBL13500477 0.80 LMNA (0.51) CNR2SMN1; SMN2LMNAMAPTNPSR1
SCHEMBL20117528 0.78 CNR2 (0.43) CNR2DHODHSMN1; SMN2LMNAPTGS2
SCHEMBL1939519 0.78 PTGS2 (0.51) DHODHL3MBTL1PTGS2PTGS1MAPT
SCHEMBL4186527 0.75 ADH5 (0.58) CNR2SMN1; SMN2TSHR
SCHEMBL25690367 0.74 CCR1 (0.34) CNR2SMN1; SMN2L3MBTL1PTGS2PTGS1
SCHEMBL9362233 0.74 GUSB (0.51) CNR2PIK3CGMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9616037-B2 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use PIMCO 2664 LIMITED (GB) 2017-04-11 US disclosed
US-20160206578-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use PIMCO 2664 LIMITED (GB) 2016-07-21 US disclosed
US-9302984-B2 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use PIMCO 2664 LIMITED (GB) 2016-04-05 US disclosed
US-20150266815-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use PIMCO 2664 LIMITED (GB) 2015-09-24 US disclosed
US-9050329-B1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use PIMCO 2664 LIMITED (GB) 2015-06-09 US disclosed
US-20150141472-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use PIMCO 2664 LIMITED (GB) 2015-05-21 US disclosed
US-20110172189-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172189-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use SOST, AADAC, ARSA CNR2 1299/4885DHODH 2602/4885SMN1; SMN2 4285/4885
US-20150141472-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use SOST, AADAC, ARSA CNR2 1277/4885DHODH 2688/4885SMN1; SMN2 4297/4885
US-20150266815-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use SOST, AADAC, ARSA CNR2 1277/4885DHODH 2688/4885SMN1; SMN2 4297/4885
US-20160206578-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use SOST, AADAC, ARSA CNR2 1277/4885DHODH 2688/4885SMN1; SMN2 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.